Peripheral Antinociception of a Chalcone, Flavokawin B and Possible Involvement of the Nitric Oxide/cyclic Guanosine Monophosphate/potassium Channels Pathway

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2013 Apr 25

PMID 23612473

Citations 6

Authors

Mohd Nasier Kamaldin

Muhammad Nadeem Akhtar

Azam Shah Mohamad

Nordin Lajis

Enoch Kumar Perimal

Ahmad Akira

Lee Ming-Tatt

Daud Ahmad Israf

Mohd Roslan Sulaiman

Affiliations

Soon will be listed here.

Abstract

Previous studies have shown that systemic administration of 6'-hydroxy-2',4'-dimethoxychalcone (flavokawin B, FKB) exerts significant peripheral and central antinociceptive effects in laboratory animals. However, the mechanisms underlying these peripheral and central antinociceptive effects have yet to be elucidated. Therefore, the objective of the present study was to evaluate the participation of nitric oxide (NO)/cyclic guanosine monophosphate (cGMP)/potassium (K+) channels pathway in the peripheral antinociception induced by FKB. It was demonstrated that intraplantar (i.pl.) administration of FKB (150, 250, 375 and 500 µg/paw) resulted in dose-dependent peripheral antinociception against mechanical hyperalgesia in carrageenan-induced hyperalgesia test model in rats. The possibility of FKB having either a central or a systemic effect was excluded since administration of FKB into the right paw did not elicit antinociception in the contralateral paw. Furthermore, peripheral antinociception induced by FKB (500 µg/paw) was significantly reduced when L-arginine (25 µg/paw, i.pl.), Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 50 µg/paw, i.pl.), glibenclamide (300 µg/paw, i.pl.), tetraethylammonium (300 µg/paw, i.pl.) and charybdotoxin (3 µg/paw, i.pl.) were injected before treatment. Taken together, our present data suggest that FKB elicits peripheral antinociception when assessed in the mechanical hyperalgesia induced by carrageenan. In addition, it was also demonstrated that this effect was mediated through interaction of the NO/cGMP/K+ channels signaling pathway.

Citing Articles

Dimethyl Itaconate Attenuates CFA-Induced Inflammatory Pain the NLRP3/ IL-1β Signaling Pathway.

Lin J, Ren J, Zhu B, Dai Y, Gao D, Xia S Front Pharmacol. 2022; 13:938979.

PMID: 35935847 PMC: 9353300. DOI: 10.3389/fphar.2022.938979.

Melanogenic Inhibition and Toxicity Assessment of Flavokawain A and B on B16/F10 Melanoma Cells and Zebrafish ().

Sakeh N, Md Razip N, Mohd Main F, Bahari M, Latif N, Akhtar M Molecules. 2020; 25(15).

PMID: 32731323 PMC: 7436045. DOI: 10.3390/molecules25153403.

Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.

Abu Bakar A, Akhtar M, Ali N, Yeap S, Quah C, Loh W Molecules. 2018; 23(3).

PMID: 29518053 PMC: 6017189. DOI: 10.3390/molecules23030616.

Zerumbone Alleviates Neuropathic Pain through the Involvement of l-Arginine-Nitric Oxide-cGMP-K⁺ ATP Channel Pathways in Chronic Constriction Injury in Mice Model.

Zulazmi N, Gopalsamy B, Min J, Farouk A, Sulaiman M, Bharatham B Molecules. 2017; 22(4).

PMID: 28358309 PMC: 6154097. DOI: 10.3390/molecules22040555.

Antinociceptive Effect of 3-(2,3-Dimethoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one in Mice Models of Induced Nociception.

Ismail N, Ming-Tatt L, Lajis N, Akhtar M, Akira A, Perimal E Molecules. 2016; 21(8).

PMID: 27556438 PMC: 6273341. DOI: 10.3390/molecules21081077.

References

Ferreira S, Duarte I, Lorenzetti B . The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol. 1991; 201(1):121-2. DOI: 10.1016/0014-2999(91)90333-l. View

Reis G, Pacheco D, Perez A, Klein A, Ramos M, Gama Duarte I . Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide. Life Sci. 2009; 85(9-10):351-6. DOI: 10.1016/j.lfs.2009.06.012. View

Mohamad A, Akhtar M, Zakaria Z, Perimal E, Khalid S, Mohd P . Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice. Eur J Pharmacol. 2010; 647(1-3):103-9. DOI: 10.1016/j.ejphar.2010.08.030. View

Romero T, Duarte I . alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat. Eur J Pharmacol. 2009; 613(1-3):64-7. DOI: 10.1016/j.ejphar.2009.04.031. View

Sulaiman M, Perimal E, Akhtar M, Mohamad A, Khalid M, Tasrip N . Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia. 2010; 81(7):855-8. DOI: 10.1016/j.fitote.2010.05.009. View

Zimmermann M . Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16(2):109-110. DOI: 10.1016/0304-3959(83)90201-4. View

Morris C . Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003; 225:115-21. DOI: 10.1385/1-59259-374-7:115. View

Moncada S, Palmer R, Higgs E . Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43(2):109-42. View

Yadav V, Prasad S, Sung B, Aggarwal B . The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol. 2010; 11(3):295-309. PMC: 3058688. DOI: 10.1016/j.intimp.2010.12.006. View

10.

Amarante L, Alves D, Duarte I . Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. Eur J Pharmacol. 2004; 494(2-3):155-60. DOI: 10.1016/j.ejphar.2004.05.009. View

11.

Ventura-Martinez R, Deciga-Campos M, Diaz-Reval M, Gonzalez-Trujano M, Lopez-Munoz F . Peripheral involvement of the nitric oxide-cGMP pathway in the indomethacin-induced antinociception in rat. Eur J Pharmacol. 2004; 503(1-3):43-8. DOI: 10.1016/j.ejphar.2004.09.018. View

12.

Jesse C, Rocha J, Nogueira C, Savegnago L . Further analysis of the antinociceptive action caused by p-methoxyl-diphenyl diselenide in mice. Pharmacol Biochem Behav. 2008; 91(4):573-80. DOI: 10.1016/j.pbb.2008.09.012. View

13.

Khalid M, Akhtar M, Mohamad A, Perimal E, Akira A, Israf D . Antinociceptive effect of the essential oil of Zingiber zerumbet in mice: possible mechanisms. J Ethnopharmacol. 2011; 137(1):345-51. DOI: 10.1016/j.jep.2011.05.043. View

14.

Alves D, Duarte I . Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol. 2002; 444(1-2):47-52. DOI: 10.1016/s0014-2999(02)01412-7. View

15.

Millan M . The induction of pain: an integrative review. Prog Neurobiol. 1999; 57(1):1-164. DOI: 10.1016/s0301-0082(98)00048-3. View

16.

Negrete R, Hervera A, Leanez S, Martin-Campos J, Pol O . The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. PLoS One. 2011; 6(10):e26688. PMC: 3198780. DOI: 10.1371/journal.pone.0026688. View

17.

Lozano-Cuenca J, Castaneda-Hernandez G, Granados-Soto V . Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib. Eur J Pharmacol. 2005; 513(1-2):81-91. DOI: 10.1016/j.ejphar.2005.02.049. View

18.

da Silva K, Manjavachi M, Paszcuk A, Pivatto M, Viegas Jr C, Bolzani V . Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models. Neuropharmacology. 2011; 62(2):967-77. DOI: 10.1016/j.neuropharm.2011.10.002. View

19.

Lin C, Senthil Kumar K, Tseng Y, Wang Z, Pan M, Xiao J . Anti-inflammatory activity of Flavokawain B from Alpinia pricei Hayata. J Agric Food Chem. 2009; 57(14):6060-5. DOI: 10.1021/jf900517d. View

20.

Mohamad A, Akhtar M, Khalivulla S, Perimal E, Khalid M, Ong H . Possible participation of nitric oxide/cyclic guanosine monophosphate/protein kinase C/ATP-sensitive K(+) channels pathway in the systemic antinociception of flavokawin B. Basic Clin Pharmacol Toxicol. 2011; 108(6):400-5. DOI: 10.1111/j.1742-7843.2010.00670.x. View